virus
becom
known
microorgan
involv
cap
adult
immunocompet
popul
recent
year
avail
data
show
viru
microorgan
isol
immunocompet
adult
hospit
cap
account
much
case
establish
etiolog
bacterium
copathogen
viru
found
associ
cap
mix
viralbacteri
pneumonia
account
much
case
etiolog
agent
identifi
studi
streptococcu
pneumonia
continu
frequent
produc
adult
cap
though
frequent
associ
copathogen
especi
virus
seem
logic
due
lower
sensit
techniqu
usual
employ
diagnos
bacteri
infect
pneumonia
consid
viral
actual
mix
cap
issu
togeth
possibl
isol
virus
asymptomat
subject
suggest
clearanc
past
current
subclin
upper
airway
infect
relat
concomit
cap
led
uncertainti
whether
virus
real
caus
cap
whether
must
act
copathogen
bacteria
adult
gener
accept
opinion
virus
influenza
rare
caus
pneumonia
healthi
adult
besid
individu
host
respons
increas
evid
sever
differ
causal
microorgan
may
trigger
differ
inflammatori
respons
level
sever
marker
white
blood
cell
wbc
creactiv
protein
crp
procalcitonin
pct
associ
differ
etiolog
pattern
clinic
sign
symptom
bacteri
viral
pneumonia
highli
variabl
overlap
clinic
radiolog
algorithm
discrimin
two
caus
cap
attempt
differenti
base
biomark
made
well
establish
crp
especi
pct
show
higher
level
bacteri
viral
atyp
pneumonia
lack
viral
pct
respons
viral
infect
thought
relat
postinfect
releas
interferon
inhibit
pct
synthesi
studi
mix
viralbacteri
cap
involv
biomark
avail
data
concern
influenza
retrospect
studi
limit
number
patient
mostli
admit
icu
show
increas
pct
crp
level
bacteri
coinfect
suggest
biomark
may
use
tool
discrimin
mix
cap
viral
cap
capnetz
studi
includ
larg
number
patient
cap
show
mix
etiolog
howev
group
heterogen
includ
two
typic
atyp
bacteria
combin
typic
atyp
bacteria
viru
want
determin
wbc
crp
pct
level
mix
viralbacteri
cap
wonder
whether
biomark
mix
diseas
show
differ
pattern
either
bacteri
viral
cap
alon
studi
receiv
written
approv
instituto
de
ciencia
de
la
salud
iac
review
board
venou
blood
sampl
collect
cap
patient
control
admiss
ed
within
hour
arriv
sampl
submit
hematolog
lab
wbc
count
anoth
sampl
edta
submit
biochemistri
lab
crp
pct
assess
latter
sampl
centrifug
store
biomark
test
perform
serum
crp
measur
mean
immunoturbidimetri
use
highli
sensit
nearinfrar
particl
immunoassay
nipia
method
immag
beckmancoult
san
diego
usa
assay
analyt
detect
limit
mgl
function
assay
sensit
mgl
procalcitonin
concentr
determin
use
sandwich
immunoassay
timeresolv
amplifi
cryptat
emiss
trace
measur
pct
sensit
kryptor
brahm
hennigsdorf
germani
describ
detail
previous
analyt
detect
limit
function
assay
sensit
assay
ngml
ngml
respect
procalcitonin
measur
pct
perform
laboratori
blind
fashion
without
know
clinic
paramet
microbiolog
result
blood
drawn
cap
patient
ed
shortli
cap
diagnosi
bacteri
cultur
sputum
obtain
possibl
antibiot
administ
immedi
sent
gram
stain
cultur
sampl
contain
preponder
leukocyt
squamou
epitheli
cell
consid
accept
anoth
blood
sampl
obtain
mycoplasma
pneumonia
complement
fixat
test
virion
serion
institut
germani
chlamydophila
pneumonia
elisa
test
savyon
diagnost
ltd
st
ashdod
israel
first
serum
test
second
serolog
test
perform
blood
obtain
followup
visit
possibl
urin
taken
first
hour
test
streptococcu
pneumonia
legionella
pneumophila
antigen
binax
binax
portland
usa
nasopharyng
aspir
obtain
process
viral
antigen
use
direct
fluoresc
antibodi
dfa
assay
two
differ
polymeras
chain
reaction
pcr
viral
test
dfa
perform
influenza
b
parainfluenza
adenoviru
adv
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
doubl
duet
dfa
respiratori
viru
screen
id
kit
diagnost
hybrid
athen
usa
first
pcr
multiplex
rtnest
pcr
assay
respiratori
virus
influenza
b
c
respiratori
syncyti
viru
b
adenoviru
coronaviru
enteroviru
parainfluenza
rhinoviru
second
test
rtpcr
commerci
kit
resplex
ii
plu
panel
qiagen
liquichip
system
hamburg
germani
detect
virus
influenza
b
rsv
b
parainfluenza
hmpv
b
enteroviru
coxsackieechoviru
rhinoviru
adenoviru
b
e
coronaviru
bocaviru
nucleic
acid
extract
nasopharyng
aspir
immedi
recept
exclud
atypicalinvolv
cap
pneumonia
c
pneumonia
patient
cap
divid
group
bacteri
viral
mix
patient
microbiolog
find
consid
cap
unknown
caus
pneumonia
potenti
pathogen
gramposit
gramneg
bacteria
classic
consid
produc
cap
haemophilu
influenza
moraxella
catarrhali
staphylococcu
aureu
etc
l
pneumophila
includ
group
bacteri
cap
one
typic
bacteria
includ
legionella
associ
one
viru
consid
mix
capvir
cap
defin
cap
detect
viru
isol
bacteria
atyp
overal
viral
bacteri
result
ad
viral
bacteri
group
cap
bacterialinvolv
addit
mix
bacteri
viral
bacteri
cap
posit
microbiolog
find
biomark
test
requir
includ
patient
studi
group
figur
descript
analysi
data
present
n
categor
variabl
median
interquartil
rang
iqr
continu
variabl
nonnorm
distribut
shown
appropri
baselin
characterist
cap
patient
compar
among
three
group
togeth
use
anova
analysi
kruskalw
h
test
depend
type
variabl
comparison
except
baselin
characterist
establish
two
differ
group
order
compar
valu
everi
biomark
differ
etiolog
group
twogroup
comparison
perform
use
utest
everi
biomark
twogroup
comparison
perform
bacteri
vs
mix
bacteri
vs
viral
mix
vs
viral
mix
vs
overal
bacteri
viral
mix
vs
unknown
pvalu
consid
indic
statist
signific
larg
number
univari
multivari
logist
regress
analys
perform
investig
factor
associ
mix
viralbacteri
cap
includ
age
comorbid
renal
failur
chronic
liver
diseas
diabet
copd
clinic
fever
dyspnea
pleurit
pain
purul
sputum
radiolog
data
type
infiltr
number
lobe
involv
sever
score
psi
biomark
pct
crp
wbc
best
model
select
stepwis
procedur
construct
receiv
oper
characterist
roc
curv
determin
area
curv
auc
auc
confid
interv
estim
biomark
predict
differ
cap
etiolog
bacteri
viral
mix
bacterialinvolv
compar
use
nonparametr
method
sensit
specif
posit
neg
predict
valu
posit
neg
likelihood
ratio
lhr
lhr
respect
calcul
cutoff
valu
biomark
statist
analysi
perform
use
spss
statist
softwar
packag
version
level
signific
statist
test
p
valu
select
patient
admit
emerg
depart
due
cap
exclud
meet
inclus
criteria
without
comprehens
microbiolog
studi
final
diagnosi
cap
discharg
total
case
final
select
figur
show
flowchart
explain
process
enrol
patient
final
three
group
follow
bacteri
viral
mix
viralbacteri
cap
main
clinic
characterist
summar
tabl
nineti
five
patient
neg
microbiolog
studi
biomark
result
unknown
caus
patient
distribut
accord
psi
score
sever
psi
andor
nonsever
psi
andor
sever
bacteri
cap
includ
psi
viral
cap
psi
mix
psi
patient
differ
found
either
clinic
score
p
psi
proport
sever
nonsever
cap
compar
three
groupsaft
exclud
atyp
lowpathogen
bacteria
select
patient
viral
bacteri
mix
cap
biomark
search
could
perform
patient
final
includ
patient
studi
etiolog
biomark
see
figur
one
patient
viral
group
anoth
mix
group
lack
pct
determin
etiolog
agent
isol
group
shown
tabl
except
atyp
serolog
everi
patient
underw
diagnost
test
streptococcu
pneumonia
frequent
agent
associ
cap
cap
known
etiolog
found
patient
bacteri
group
singl
microorgan
associ
bacteria
also
identifi
mix
bacterialvir
etiolog
preval
associ
pneumonia
rhinoviru
influenza
adenoviru
viral
cap
group
frequent
isol
pathogen
influenza
adenoviru
rhinoviru
case
pneumonia
pneumonia
isol
associ
virus
virus
involv
case
cap
establish
caus
exclud
atyp
wherea
known
etiolog
mix
bacterialvir
etiolog
inform
summar
tabl
control
group
compos
subject
match
age
sex
comorbid
group
similar
cap
patient
biomark
level
check
nasopharyng
aspir
obtain
subject
viral
search
includ
pcr
test
pair
blood
sampl
serolog
studi
obtain
subject
control
group
virus
adenoviru
parainfluenza
isol
subject
pct
crp
wbc
significantli
higher
cap
patient
control
shown
tabl
bacteri
mix
cap
show
differ
pct
p
viral
cap
significantli
lower
pct
valu
bacteri
mix
p
respect
crp
significantli
higher
mix
cap
bacteri
p
viral
p
cap
differ
latter
two
group
p
pct
crp
show
significantli
higher
valu
mix
group
compar
overal
viral
bacteri
cap
unknown
caus
wbc
count
bacteri
mix
viral
cap
show
differ
among
three
group
p
tabl
see
figur
pct
crp
wbc
show
similar
result
influenza
cap
noninfluenza
viral
cap
p
respect
tabl
influenza
b
remov
viral
n
mix
n
group
pct
crp
level
show
significantli
higher
level
mix
cap
compar
viral
cap
without
influenza
p
respect
wbc
show
differ
either
biomark
tabl
crp
level
also
higher
mix
involv
influenza
viral
cap
due
influenza
viru
tabl
differenti
mix
overal
bacteri
viral
cap
cutoff
crp
mgdl
near
median
valu
show
ppv
ci
npv
regard
pct
cutoff
ngml
near
median
valu
discrimin
bacterialinvolv
bacteri
mix
viral
cap
posit
predict
posit
valu
ppv
confid
interv
ci
neg
predict
valu
npv
ci
larg
number
univari
multivari
logist
regress
analys
perform
investig
factor
associ
mix
viralbacteri
cap
final
multivari
logist
regress
model
select
stepwis
procedur
includ
one
independ
variabl
crp
independ
factor
associ
mix
etiolog
paramet
show
associ
viralbacteri
cap
adjust
rest
variabl
tabl
receiv
oper
characterist
roc
analysi
pct
discrimin
bacterialinvolv
bacteri
mix
viral
cap
show
area
curv
auc
p
auc
p
discrimin
bacteri
viral
cap
p
discrimin
mix
viral
cap
crp
auc
discrimin
bacterialinvolv
viral
cap
signific
p
differ
mix
bacteri
p
mix
viral
p
mix
overal
bacteri
viral
p
tabl
see
figur
main
conclus
studi
biomark
adult
immunocompet
mix
viralbacteri
cap
show
differ
inflammatori
behavior
bacteri
viral
cap
follow
mix
cap
similar
pct
level
bacteri
cap
differ
viral
cap
crp
level
higher
mix
either
bacteri
viral
cap
tabl
pct
crp
level
higher
mix
overal
viral
bacteri
group
cap
unknown
caus
tabl
differ
associ
differ
sever
b
pct
level
ngml
admiss
may
indic
bacterialinvolv
pneumonia
bacteri
mix
viralbacteri
high
probabl
elev
crp
level
independ
factor
associ
mix
etiolog
valu
mgml
rule
mix
etiolog
probabl
recent
year
studi
shown
import
mix
viralbacteri
pneumonia
report
preval
cap
adult
cap
known
etiolog
wide
rang
due
differ
studi
design
especi
number
type
diagnost
techniqu
use
studi
includ
everi
test
commonli
use
clinic
practic
well
two
differ
pcr
assay
respiratori
virus
techniqu
standard
order
obtain
complet
viru
yield
possibl
follow
protocol
abl
identifi
definit
group
mix
pneumonia
compar
pure
bacteri
viral
group
import
mix
cap
recogn
recent
year
clearli
underestim
far
studi
found
type
cap
sever
bacteri
cap
wherea
other
like
studi
found
differ
etiologyrel
sever
import
suspect
mix
cap
justifi
case
sever
virus
isol
treat
mix
bacterialvir
cap
pneumococcu
caus
agent
half
pneumonia
pneumonia
associ
virus
data
indic
mani
case
cap
usual
consid
pneumococc
cap
realiti
mix
viralbacteri
infect
virus
usual
look
convers
viral
pcr
use
mani
consid
viral
cap
realiti
mix
miss
bacteria
true
viral
genom
may
isol
upper
airway
asymptomat
subject
therefor
patient
cap
may
suggest
previou
concomit
upper
respiratori
viral
infect
unrel
pneumonia
studi
includ
bal
sever
cap
found
viral
genom
identifi
upper
respiratori
sampl
without
alveolar
isol
case
identifi
viru
control
similar
studi
author
clear
whether
virus
influenza
caus
pneumonia
adult
whether
must
act
conjunct
respiratori
pathogen
rhinoviru
common
viru
identifi
bal
patient
sever
cap
recent
studi
data
show
differ
inflammatori
respons
pure
viral
pneumonia
compar
bacterialvir
cap
also
suggest
virus
influenza
caus
pneumonia
adult
patient
inform
literatur
confirm
viral
pneumonia
induc
differ
biomark
respons
compar
bacteri
pneumonia
fact
studi
confirm
differ
also
includ
atyp
lack
pct
respons
viral
diseas
seem
due
stimul
macrophag
releas
interferon
inhibit
tumor
necrosi
factor
tnf
synthesi
turn
necessari
tissu
synthes
pct
studi
pct
level
similar
mix
bacteri
cap
higher
viral
cap
term
crp
found
mix
cap
show
significantli
higher
level
bacteri
viral
pneumonia
biomark
independ
factor
associ
mix
etiolog
high
npv
crp
help
us
suspect
aetiolog
differ
mix
bacterialvir
howev
true
low
ppv
auc
limit
use
clinic
set
studi
suggest
potenti
role
biomark
differenti
pandem
influenza
cap
bacteri
coinfect
studi
retrospect
involv
limit
number
mainli
critic
icu
patient
largest
seri
includ
case
mix
cap
found
lower
level
pct
pct
crp
viral
cap
mix
cap
well
util
clinic
practic
howev
other
show
limit
sensit
specif
also
found
serum
crp
higher
mix
infect
involv
influenza
differ
could
achiev
pct
probabl
due
low
number
case
n
except
influenza
inform
adult
behavior
biomark
mix
pneumonia
studi
found
inflammatori
respons
higher
mix
cap
compar
singl
bacteri
viral
cap
includ
mix
viralbacteri
cap
restrict
influenza
viru
homogen
adult
group
patient
pct
crp
differ
viral
cap
without
influenza
mix
cap
without
influenza
abil
crp
discrimin
mix
viralbacteri
cap
bacteri
cap
consid
limit
children
capnetz
group
show
case
mix
cap
adult
includ
two
typic
atyp
bacteria
combin
typic
atyp
bacteria
viru
pct
crp
level
test
togeth
although
increas
amount
biomark
especi
pct
associ
increas
pneumonia
sever
case
studi
found
differ
either
psi
score
among
three
etiolog
group
median
crp
highest
mix
cap
perhap
reflect
increas
level
system
inflamm
suggest
difficult
explain
accuraci
mix
cap
show
higher
crp
level
viral
bacteri
pneumonia
recent
suggest
main
etiolog
agent
cap
present
differ
inflammatori
profil
accord
respect
biomark
crp
pct
respons
hostmicroorgan
interplay
may
use
etiolog
diagnosi
result
suggest
mix
bacterialvir
cap
predomin
crp
respons
find
investig
approach
use
pct
crp
etiolog
diagnosi
cap
contradictori
due
least
part
lack
inclus
mix
bacterialvir
pneumonia
studi
differ
wbc
count
among
three
etiolog
group
studi
subject
certain
limit
studi
singl
hospit
limit
number
patient
obtain
lower
respiratori
tract
sampl
bal
viral
studi
nasopharyng
viral
find
may
come
concomit
viral
upper
respiratori
infect
use
pcr
techniqu
diagnos
atyp
bacteria
yield
pathogen
base
serolog
test
low
nevertheless
purpos
studi
virus
bacteria
atyp
find
exclud
awar
pneumonia
classifi
viral
could
fact
mix
bacteria
could
identifi
without
quantifi
pcr
test
bacteria
final
sequenti
search
biomark
might
given
us
complet
inform
major
strength
studi
compar
well
defin
popul
mix
cap
group
well
defin
bacteri
viral
cap
find
suggest
specif
inflammatori
profil
mix
viralbacteri
cap
differ
bacteri
viral
cap
find
use
clinician
includ
antivir
treatment
especi
influenza
season
suspect
bacteri
role
case
either
symptom
suggest
viru
involv
viral
isol
interestingli
result
similar
exclud
mix
influenza
case
first
studi
assess
biomark
group
mix
viralbacteri
cap
influenza
compar
bacteri
viral
adult
cap
biomark
profil
group
differ
viral
cap
suggest
inflammatori
respons
virus
even
exclud
influenza
differ
mix
cap
therefor
virus
alway
requir
bacteri
copathogen
produc
pneumonia
adult
may
help
us
better
understand
true
role
virus
cap
perhap
encourag
develop
effect
antivir
drug
despit
use
particular
case
appear
lack
accur
biomark
separ
bacterialinvolv
cap
viral
cap
clinic
practic
cap
communityaquir
pneumonia
pct
procalcitonin
crp
c
reactiv
protein
wbc
white
blood
cell
nipia
nearinfrar
particl
immunoassay
trace
timeresolv
amplifi
cryptat
emiss
pcr
polymeras
chain
reaction
dfa
direct
fluoresc
antibodi
assay
adv
adenoviru
hmpv
human
metapneumoviru
rsv
respiratori
syncyti
viru
author
declar
compet
interest
concept
design
sb
em
rm
acquisit
data
sb
em
sf
abl
mar
al
cp
rm
analysi
interpret
data
cl
rm
abl
sb
draft
revis
articl
sb
em
sf
abl
cl
mar
al
cp
rm
final
approv
manuscript
sb
em
sf
abl
mar
al
cp
cl
rm
prepubl
histori
paper
access
http
